Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System injury2017

NCT03291366 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.

NCT NCT03291366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03291366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System injury2017
Lead sponsor
Fuzhou General Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2017
Completion date
January 31, 2022
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system injury